- Home
- CR vs HSIC Comparison
CR vs HSIC Comparison
Compare CR & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CR
- HSIC
- Stock Information
- Founded
- CR 1855
- HSIC 1932
- Country
- CR United States
- HSIC United States
- Employees
- CR N/A
- HSIC N/A
- Industry
- CR Metal Fabrications
- HSIC Medical Specialities
- Sector
- CR Industrials
- HSIC Health Care
- Exchange
- CR Nasdaq
- HSIC Nasdaq
- Market Cap
- CR 8.9B
- HSIC 9.0B
- IPO Year
- CR N/A
- HSIC 1995
- Fundamental
- Price
- CR $192.41
- HSIC $74.48
- Analyst Decision
- CR Strong Buy
- HSIC Buy
- Analyst Count
- CR 4
- HSIC 10
- Target Price
- CR $197.75
- HSIC $79.30
- AVG Volume (30 Days)
- CR 388.9K
- HSIC 1.5M
- Earning Date
- CR 07-28-2025
- HSIC 08-05-2025
- Dividend Yield
- CR 0.48%
- HSIC N/A
- EPS Growth
- CR 54.50
- HSIC 8.11
- EPS
- CR 5.76
- HSIC 3.21
- Revenue
- CR $2,178,600,000.00
- HSIC $12,669,000,000.00
- Revenue This Year
- CR $10.22
- HSIC $4.28
- Revenue Next Year
- CR $11.07
- HSIC $3.57
- P/E Ratio
- CR $33.41
- HSIC $23.21
- Revenue Growth
- CR 17.22
- HSIC 1.75
- 52 Week Low
- CR $127.04
- HSIC $60.56
- 52 Week High
- CR $193.35
- HSIC $82.49
- Technical
- Relative Strength Index (RSI)
- CR 72.77
- HSIC 68.04
- Support Level
- CR $186.53
- HSIC $72.21
- Resistance Level
- CR $193.35
- HSIC $75.34
- Average True Range (ATR)
- CR 3.64
- HSIC 1.32
- MACD
- CR 0.37
- HSIC 0.24
- Stochastic Oscillator
- CR 94.56
- HSIC 85.04
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.